ANDREW I. KOVEN

Insider Reports History

Location
New York, NY
Signature
/s/ Phillip Torrence, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANDREW I. KOVEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. Director Common Stock 16,972 $59,062 $3.48 15 Jun 2025 Direct
MetaVia Inc. Director Common Stock 45,699 $35,188 $0.7700 30 Jun 2025 Direct
KALA BIO, Inc. Director Stock Option (right to buy) 6,850 15 Jun 2025 Direct

Insider Reports Filed by ANDREW I. KOVEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MTVA MetaVia Inc. 30 Jun 2025 1 $0 4 Director 01 Jul 2025, 16:01
KALA KALA BIO, Inc. 15 Jun 2025 2 $0 4 Director 17 Jun 2025, 20:00
KALA KALA BIO, Inc. 11 Jun 2024 2 $0 4 Director 12 Jun 2024, 20:00
MTVA NeuroBo Pharmaceuticals, Inc. 07 Jun 2024 1 $0 4 Director 07 Jun 2024, 19:25
MTVA NeuroBo Pharmaceuticals, Inc. 27 Jul 2023 2 $0 4 Director 28 Jul 2023, 06:19
KALA Kala Pharmaceuticals, Inc. 22 Jun 2023 4 $0 4 Director 23 Jun 2023, 20:00
KALA Kala Pharmaceuticals, Inc. 31 May 2023 5 $0 4 Director 02 Jun 2023, 20:00
KALA Kala Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:45
MTVA NeuroBo Pharmaceuticals, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 17:21
MTVA NeuroBo Pharmaceuticals, Inc. 02 Sep 2021 1 $0 4 Director 03 Sep 2021, 11:43
MTVA NeuroBo Pharmaceuticals, Inc. 09 Jul 2021 0 $0 3 Director 19 Jul 2021, 17:17
KALA Kala Pharmaceuticals, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:30